Patient preferences are increasingly seen as valuable in healthcare policy decision-making, but such studies are not always easy to design and implement, writes Nick Hicks.
Nick Hicks
Advertisement
Nick Hicks
is principal of Commutateur, a healthcare coaching and communications agency.
Articles by Nick Hicks
As pharma continues to move towards "beyond the pill" strategies, better understanding of patients' sometimes paradoxical view of disease can help lead to strategies for helping them live more productive lives, writes Nick Hicks.
Nick Hicks looks at the challenges of devising a patient advocacy strategy amid the complex political, cultural and regulatory landscape of Russia and CIS.
Advertisement
Latest Updated Articles
What Makes a Good Patient Advocacy Strategy in Russia and CIS?Published: October 1st 2015 | Updated: July 25th 2023
- The Paradox of Disease: Pointers for Better Patient Centricity?
Published: October 5th 2015 | Updated: November 15th 2020
Patient Input and Patient Preference StudiesPublished: March 18th 2019 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Real-World Data Brings New Insights to Natural History of Disease Studies
2
FDA Approves Hernexeos Under National Priority Voucher Program
3
Pharmaceutical Executive Daily: FDA Approves Palynziq and Sogroya
4
Alkermes Reveals CEO Succession Plan Following Richard Pops’ Retirement Announcement
5